Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1964 1
1966 1
1967 1
1968 2
1969 1
1970 2
1974 2
1975 3
1976 1
1978 2
1979 3
1980 3
1981 3
1982 5
1983 13
1984 3
1985 7
1986 9
1987 8
1988 11
1989 4
1990 10
1991 9
1992 15
1993 9
1994 13
1995 16
1996 23
1997 12
1998 16
1999 8
2000 18
2001 11
2002 12
2003 17
2004 19
2005 22
2006 27
2007 23
2008 24
2009 24
2010 25
2011 25
2012 40
2013 39
2014 40
2015 54
2016 52
2017 60
2018 69
2019 67
2020 68
2021 87
2022 53
2023 31
2024 51
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,060 results

Results by year

Filters applied: . Clear all
Page 1
HTLV in Sweden.
Vesterbacka J, Svensson AK, Nowak P. Vesterbacka J, et al. Among authors: svensson ak. AIDS Rev. 2024;26(1):41-47. doi: 10.24875/AIDSRev.24000002. AIDS Rev. 2024. PMID: 38530748 Review.
STROBE and reporting observational studies in dermatology.
Langan SM, Schmitt J, Coenraads PJ, Svensson A, von Elm E, Williams HC; European Dermato-Epidemiology Network (EDEN). Langan SM, et al. Among authors: svensson a. Br J Dermatol. 2011 Jan;164(1):1-3. doi: 10.1111/j.1365-2133.2010.10136.x. Br J Dermatol. 2011. PMID: 21175559 No abstract available.
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.
Sundén-Cullberg J, Chen P, Häbel H, Skorup P, Janols H, Rasmuson J, Niward K, Östholm Balkhed Å, Chatzidionysiou K, Asgeirsson H, Blennow O, Parke Å, Svensson AK, Muvva JR, Ljunggren HG; Karolinska KI/K COVID-19 Treatment Working Group; Horne AC, Ådén U, Henter JI, Sönnerborg A, Vesterbacka J, Nowak P, Lampa J. Sundén-Cullberg J, et al. Among authors: svensson ak. PLoS One. 2023 Dec 29;18(12):e0295838. doi: 10.1371/journal.pone.0295838. eCollection 2023. PLoS One. 2023. PMID: 38157348 Free PMC article. Clinical Trial.
Prevalence of prurigo nodularis in Sweden.
Antelmi A, Metsini A, Regnell SE, Carlberg M, Svensson Å, von Kobyletzki L. Antelmi A, et al. Among authors: svensson a. J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e904-e906. doi: 10.1111/jdv.19986. Epub 2024 Mar 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38553871 No abstract available.
Molecular diagnostics in hemostatic disorders.
Perrotta PL, Svensson AM. Perrotta PL, et al. Among authors: svensson am. Clin Lab Med. 2009 Jun;29(2):367-90. doi: 10.1016/j.cll.2009.04.001. Clin Lab Med. 2009. PMID: 19665683 Review.
Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement.
Chernyshov PV, Tomas-Aragones L, Zuberbier T, Kocatürk E, Manolache L, Pustisek N, Svensson Å, Marron SE, Sampogna F, Bewley A, Salavastru C, Koumaki D, Augustin M, Linder D, Abeni D, Salek SS, Szepietowski JC, Jemec GB. Chernyshov PV, et al. Among authors: svensson a. Int J Dermatol. 2024 Dec;63(12):1657-1667. doi: 10.1111/ijd.17366. Epub 2024 Jul 4. Int J Dermatol. 2024. PMID: 38965063 Review.
1,060 results